These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22802423)

  • 1. How could we improve the increased cardiovascular mortality in patients with overt and subclinical hyperthyroidism?
    Biondi B
    Eur J Endocrinol; 2012 Sep; 167(3):295-9. PubMed ID: 22802423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical hyperthyroidism and cardiovascular risk: recommendations for treatment.
    Palmeiro C; Davila MI; Bhat M; Frishman WH; Weiss IA
    Cardiol Rev; 2013; 21(6):300-8. PubMed ID: 23563523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperthyroidism and cardiovascular morbidity and mortality.
    Osman F; Gammage MD; Franklyn JA
    Thyroid; 2002 Jun; 12(6):483-7. PubMed ID: 12165110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invited commentary: Cardiovascular mortality in subclinical hyperthyroidism: an ongoing dilemma.
    Biondi B
    Eur J Endocrinol; 2010 Mar; 162(3):587-9. PubMed ID: 20064895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid hormone use, hyperthyroidism and mortality in older women.
    Bauer DC; Rodondi N; Stone KL; Hillier TA; ;
    Am J Med; 2007 Apr; 120(4):343-9. PubMed ID: 17398229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between thyroid-stimulating hormone and the occurrence of cardiovascular events and mortality in patients with manifest vascular diseases.
    Westerink J; van der Graaf Y; Faber DR; Spiering W; Visseren FL;
    Eur J Prev Cardiol; 2012 Aug; 19(4):864-73. PubMed ID: 21724680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical review and meta-analysis of the association between overt hyperthyroidism and mortality.
    Brandt F; Green A; Hegedüs L; Brix TH
    Eur J Endocrinol; 2011 Oct; 165(4):491-7. PubMed ID: 21724839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular morbidity and mortality in thyroid dysfunction.
    Dörr M; Völzke H
    Minerva Endocrinol; 2005 Dec; 30(4):199-216. PubMed ID: 16319809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients.
    Drechsler C; Schneider A; Gutjahr-Lengsfeld L; Kroiss M; Carrero JJ; Krane V; Allolio B; Wanner C; Fassnacht M
    Am J Kidney Dis; 2014 Jun; 63(6):988-96. PubMed ID: 24315768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease and thyroid function.
    Faber J; Selmer C
    Front Horm Res; 2014; 43():45-56. PubMed ID: 24943297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclinical hyperthyroidism and the risk of cardiovascular events and all-cause mortality: an updated meta-analysis of cohort studies.
    Yang LB; Jiang DQ; Qi WB; Zhang T; Feng YL; Gao L; Zhao J
    Eur J Endocrinol; 2012 Jul; 167(1):75-84. PubMed ID: 22535645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study.
    Selmer C; Olesen JB; Hansen ML; von Kappelgaard LM; Madsen JC; Hansen PR; Pedersen OD; Faber J; Torp-Pedersen C; Gislason GH
    J Clin Endocrinol Metab; 2014 Jul; 99(7):2372-82. PubMed ID: 24654753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular events in thyroid disease: a population based, prospective study.
    Schultz M; Kistorp C; Raymond I; Dimsits J; Tuxen C; Hildebrandt P; Faber J
    Horm Metab Res; 2011 Aug; 43(9):653-9. PubMed ID: 21823062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review: The association of thyroid dysfunction with all-cause and circulatory mortality: is there a causal relationship?
    Völzke H; Schwahn C; Wallaschofski H; Dörr M
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2421-9. PubMed ID: 17473067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis.
    Singh S; Duggal J; Molnar J; Maldonado F; Barsano CP; Arora R
    Int J Cardiol; 2008 Mar; 125(1):41-8. PubMed ID: 17434631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid function and mortality in patients treated for hyperthyroidism.
    Franklyn JA; Sheppard MC; Maisonneuve P
    JAMA; 2005 Jul; 294(1):71-80. PubMed ID: 15998893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selected markers of endothelial dysfunction in patients with subclinical and overt hyperthyroidism].
    Modzelewska A; Szelachowska M; Zonenberg A; Abdelrazek S; Nikołajuk A; Górska M
    Endokrynol Pol; 2006; 57(3):202-10. PubMed ID: 16832783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of second and third generation methods for measurement of serum thyrotropin in patients with overt hyperthyroidism, patients receiving thyroxine therapy, and those with nonthyroidal illness.
    Franklyn JA; Black EG; Betteridge J; Sheppard MC
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1368-71. PubMed ID: 8200938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Association of Overt and Subclinical Hyperthyroidism with the Risk of Cardiovascular Events and Cardiovascular Mortality: Meta-Analysis and Systematic Review of Cohort Studies.
    Sohn SY; Lee E; Lee MK; Lee JH
    Endocrinol Metab (Seoul); 2020 Dec; 35(4):786-800. PubMed ID: 33238332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Thyroid Epidemiology, Audit, and Research Study (TEARS): morbidity in patients with endogenous subclinical hyperthyroidism.
    Vadiveloo T; Donnan PT; Cochrane L; Leese GP
    J Clin Endocrinol Metab; 2011 May; 96(5):1344-51. PubMed ID: 21346066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.